Literature DB >> 17286741

Ventricular cerebrospinal fluid melatonin concentrations investigated with an endoscopic technique.

Pierluigi Longatti1, Alessandro Perin, Vittoria Rizzo, Stefano Comai, Pietro Giusti, Carlo Virgilio Luigi Costa.   

Abstract

The role of melatonin in humans still remains unclear. Uncertainties persist about its effects on neurophysiology regarding its levels in human cerebrospinal fluid (CSF), as the bulk of knowledge on this subject mainly derives from studies conducted on animals. In this study, CSF was micro-sampled with a simple, new method from each cerebral ventricle of patients undergoing neuroendoscopy for hydrocephalus. Our purpose was to measure CSF melatonin levels and determine possible differences in its concentration among various significant areas in the cerebral ventricles (e.g. pineal recess, pituitary recess, lateral ventricle, fourth ventricle) and lumbar cistern. From 2002 to 2004, 10 hydrocephalic patients were operated on using a neuroendoscopic technique. The CSF specimens were investigated for melatonin concentrations (free plus protein-bound) after deproteinization; the measurement technique was high-performance liquid chromatography. The preliminary data obtained with this endoscopic micro-sampling technique (applied to humans for the first time) suggest that melatonin is more concentrated within the ventricles and its highest concentration is found in the third ventricle (IIIv), although the difference detected between the CSF of the IIIv and that of the pineal recess was not significant.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17286741     DOI: 10.1111/j.1600-079X.2006.00391.x

Source DB:  PubMed          Journal:  J Pineal Res        ISSN: 0742-3098            Impact factor:   13.007


  9 in total

1.  Melatonin as an adjuvant therapy in patients with rheumatoid arthritis.

Authors:  Ahmet Korkmaz
Journal:  Br J Clin Pharmacol       Date:  2008-05-27       Impact factor: 4.335

2.  The suprapineal recess of the third ventricle: an anatomic study with magnetic resonance imaging.

Authors:  Satoshi Tsutsumi; Hideo Ono; Yukimasa Yasumoto
Journal:  Surg Radiol Anat       Date:  2016-12-09       Impact factor: 1.246

Review 3.  Extrapineal melatonin: sources, regulation, and potential functions.

Authors:  Darío Acuña-Castroviejo; Germaine Escames; Carmen Venegas; María E Díaz-Casado; Elena Lima-Cabello; Luis C López; Sergio Rosales-Corral; Dun-Xian Tan; Russel J Reiter
Journal:  Cell Mol Life Sci       Date:  2014-02-20       Impact factor: 9.261

Review 4.  Role of melatonin in metabolic regulation.

Authors:  Ahmet Korkmaz; Turgut Topal; Dun-Xian Tan; Russel J Reiter
Journal:  Rev Endocr Metab Disord       Date:  2009-12       Impact factor: 6.514

5.  Significance of high levels of endogenous melatonin in Mammalian cerebrospinal fluid and in the central nervous system.

Authors:  Dun-Xian Tan; Lucien C Manchester; Emilio Sanchez-Barcelo; Maria D Mediavilla; Russel J Reiter
Journal:  Curr Neuropharmacol       Date:  2010-09       Impact factor: 7.363

6.  Preoperative CSF Melatonin Concentrations and the Occurrence of Delirium in Older Hip Fracture Patients: A Preliminary Study.

Authors:  Rikie M Scholtens; Sophia E J A de Rooij; Annelies E Vellekoop; Bart C Vrouenraets; Barbara C van Munster
Journal:  PLoS One       Date:  2016-12-09       Impact factor: 3.240

Review 7.  The neuroprotective role of melatonin in neurological disorders.

Authors:  B S Alghamdi
Journal:  J Neurosci Res       Date:  2018-03-01       Impact factor: 4.164

8.  Investigating the relationship between melatonin levels, melatonin system, microbiota composition and bipolar disorder psychopathology across the different phases of the disease.

Authors:  Mirko Manchia; Alessio Squassina; Claudia Pisanu; Donatella Congiu; Mario Garzilli; Beatrice Guiso; Federico Suprani; Pasquale Paribello; Vittoria Pulcinelli; Maria Novella Iaselli; Federica Pinna; Flavia Valtorta; Bernardo Carpiniello; Stefano Comai
Journal:  Int J Bipolar Disord       Date:  2019-12-09

9.  Inhibitory effects of pharmacological doses of melatonin on aromatase activity and expression in rat glioma cells.

Authors:  A González; C Martínez-Campa; M D Mediavilla; C Alonso-González; E J Sánchez-Barceló; S Cos
Journal:  Br J Cancer       Date:  2007-08-14       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.